Finalised programme for the Autumn meeting:
12:00 – 13:30 | Registration and lunch |
13:30 – 13:45 | Mike Atkinson: Morriston Hospital Current trend of Diabetic Ketoacidosis admission in Adults with Type 1 Diabetes in Wales |
13:45 – 14:00 | Stephanie Hanna; Cardiff University School of Medicine Intradermal injection of diabetes autoantigens results in recruitment of clonally expanded antigen specific T cells to skin and draining lymph nodes and facilitates monitoring of autoimmune response |
14:00 – 14:15 | Helen Saunders; Hywel Dda Health Board Role of Flash Glucose Monitoring in community diabetes care |
14:15 – 14.30 | Romesh John; University Hospital of Wales Prevalence of thromboembolic events in 51 patients treated for Cushing’s Disease with Pituitary surgery at University Hospital of Wales over a 15-year period |
14:30 – 14:45 | Richard Roberts; Morriston Hospital Demographic differences in older adults with and without type 2 diabetes presenting to the Older Persons Assessment Service, Morriston Emergency Department |
14:45 – 15:00 | Peter Taylor; University Hospital of Wales Individuals on levothyroxine have higher HADS anxiety and depression scores than the general population and this is exacerbated by the Thr92Ala substitution in DIO2 |
15:00 – 15.15 | Megan Evans; University Hospital of Wales An audit to evaluate the care of women with Turner’s Syndrome at the University Hospital of Wales |
15:15 – 15:30 | David Butler; Research Liaison Manager, Cardiff & Vale UHB Research studies open to recruitment: an update |
15.30 – 16.15 | C O F F E E B R E A K |
16:15 – 16.30 | Lynnette James – Pharmacist – Cardiff and Vale UHB Safety measures and resources for patients at risk of adrenal insufficiency |
16.30 – 16.45 | Kyi Min Sann; Glan Clwyd Hospital Uncommon presentation of adrenal insufficiency due to exotic infection |
16:45 – 17:00 | Anna De Lloyd; Cardiff & Vale UHB Conceived in the Chernobyl exclusion zone; a case discussion |
17:00 – 17.15 | Giselle Sharaf; Royal Glamorgan Hospital Fibroblast Growth Factor 23 – Mediated Hypophosphataemia: A Case Report |
17.15 – 18.00 | GUEST SPEAKER: Richard Quinton – Newcastle Upon Tyne Hospital Is there any cardiovascular risk associated with testosterone treatment of hypogonadalmen? Lessons from the TestES study |
18.00 | Meeting closed |
19:00 | Dinner |
20:30 | WEDS Meeting End |
The organisers would like to thank the following companies for their sponsorship of the meeting:
No pharmaceutical companies have had any input into the agenda. Pharmaceutical companies
have sponsored the meeting through purchase of an exhibition stand. Acknowledgement of
sponsorship shown on the printed Programme, Abstract Booklet and on the WEDS Website.